FI895005A0 - Immunotoxiner foer behandling och profylax av autoimmuna sjukdomar. - Google Patents
Immunotoxiner foer behandling och profylax av autoimmuna sjukdomar.Info
- Publication number
- FI895005A0 FI895005A0 FI895005A FI895005A FI895005A0 FI 895005 A0 FI895005 A0 FI 895005A0 FI 895005 A FI895005 A FI 895005A FI 895005 A FI895005 A FI 895005A FI 895005 A0 FI895005 A0 FI 895005A0
- Authority
- FI
- Finland
- Prior art keywords
- profylax
- immunotoxiner
- autoimmuna
- sjukdomar
- foer behandling
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
- A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
- A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
- A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
- A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
- A61K47/6811—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a protein or peptide, e.g. transferrin or bleomycin
- A61K47/6817—Toxins
- A61K47/6819—Plant toxins
- A61K47/6825—Ribosomal inhibitory proteins, i.e. RIP-I or RIP-II, e.g. Pap, gelonin or dianthin
- A61K47/6827—Ricin A
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K51/00—Preparations containing radioactive substances for use in therapy or testing in vivo
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Toxicology (AREA)
- Botany (AREA)
- Rheumatology (AREA)
- Pain & Pain Management (AREA)
- Molecular Biology (AREA)
- Transplantation (AREA)
- Physics & Mathematics (AREA)
- Optics & Photonics (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP88202349 | 1988-10-21 | ||
| EP88202349 | 1988-10-21 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FI895005A0 true FI895005A0 (fi) | 1989-10-20 |
| FI100305B FI100305B (fi) | 1997-11-14 |
Family
ID=8199870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FI895005A FI100305B (fi) | 1988-10-21 | 1989-10-20 | Menetelmä autoimmuunisairauden hoitoon tai ennaltaehkäisyyn käyttökelp oisen immunotoksiinin valmistamiseksi |
Country Status (15)
| Country | Link |
|---|---|
| EP (1) | EP0365087B1 (fi) |
| JP (1) | JP2807506B2 (fi) |
| KR (1) | KR0151851B1 (fi) |
| AT (1) | ATE78407T1 (fi) |
| AU (1) | AU625802B2 (fi) |
| CA (1) | CA2000999A1 (fi) |
| DE (1) | DE68902212T2 (fi) |
| DK (1) | DK523589A (fi) |
| ES (1) | ES2051989T3 (fi) |
| FI (1) | FI100305B (fi) |
| GR (1) | GR3006048T3 (fi) |
| IE (1) | IE61831B1 (fi) |
| NZ (1) | NZ231095A (fi) |
| PT (1) | PT92071B (fi) |
| ZA (1) | ZA897895B (fi) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU3423293A (en) * | 1991-12-19 | 1993-07-19 | Baylor College Of Medicine | Pva or peg conjugates of peptides for epitope-specific immunosuppression |
| AU5132499A (en) | 1998-08-11 | 2000-03-06 | Rush - Presbyterian - St. Luke's Medical Center | Methods and compositions for preventing anti-gal production in xenograft recipients |
| KR100346059B1 (ko) * | 1999-12-30 | 2002-07-24 | 주식회사 효성 | 폴리에스테르 섬유의 제조방법 |
| EP2359837A1 (en) * | 2006-11-23 | 2011-08-24 | Cadila Pharmaceuticals Ltd. | Poly-tlr antagonist |
| JP7303107B2 (ja) * | 2016-08-12 | 2023-07-04 | イムノワーク，リミテッド ライアビリティ カンパニー | 自己免疫疾患の診断、予防、および／または治療 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IL69686A (en) * | 1983-09-11 | 1988-03-31 | Yeda Res & Dev | Compositions containing cell membrane proteins and process for their preparation |
| DE3513572A1 (de) * | 1985-04-16 | 1986-10-16 | Karl Prof. Dr.med. 7302 Ostfildern Theurer | Herstellung von praeparaten zur spezifischen beeinflussung der humoralen und zellulaeren immunreaktion |
| NL8701163A (nl) * | 1986-09-09 | 1988-04-05 | Nederlanden Staat | Gebruik van een peptide voor de bereiding van preparaten voor het verlichten, het behandelen en de diagnose van autoimmuunziekten, in het bijzonder arthritische toestanden, verbindingen die met dit peptide verwant zijn, alsmede farmaceutische en diagnostische preparaten en testkits. |
-
1989
- 1989-10-13 ES ES89202588T patent/ES2051989T3/es not_active Expired - Lifetime
- 1989-10-13 EP EP89202588A patent/EP0365087B1/en not_active Expired - Lifetime
- 1989-10-13 AT AT89202588T patent/ATE78407T1/de not_active IP Right Cessation
- 1989-10-13 DE DE8989202588T patent/DE68902212T2/de not_active Expired - Fee Related
- 1989-10-16 IE IE332489A patent/IE61831B1/en not_active IP Right Cessation
- 1989-10-18 ZA ZA897895A patent/ZA897895B/xx unknown
- 1989-10-19 CA CA002000999A patent/CA2000999A1/en not_active Abandoned
- 1989-10-20 AU AU43595/89A patent/AU625802B2/en not_active Ceased
- 1989-10-20 DK DK523589A patent/DK523589A/da not_active Application Discontinuation
- 1989-10-20 FI FI895005A patent/FI100305B/fi not_active IP Right Cessation
- 1989-10-20 JP JP1274783A patent/JP2807506B2/ja not_active Expired - Lifetime
- 1989-10-20 PT PT92071A patent/PT92071B/pt not_active IP Right Cessation
- 1989-10-20 NZ NZ231095A patent/NZ231095A/en unknown
- 1989-10-21 KR KR1019890015214A patent/KR0151851B1/ko not_active IP Right Cessation
-
1992
- 1992-10-22 GR GR920402373T patent/GR3006048T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| KR0151851B1 (ko) | 1998-10-15 |
| DK523589D0 (da) | 1989-10-20 |
| DK523589A (da) | 1990-04-22 |
| AU4359589A (en) | 1990-04-26 |
| PT92071A (pt) | 1990-04-30 |
| DE68902212T2 (de) | 1993-05-27 |
| IE61831B1 (en) | 1994-11-30 |
| KR900005996A (ko) | 1990-05-07 |
| GR3006048T3 (fi) | 1993-06-21 |
| PT92071B (pt) | 1995-06-30 |
| ATE78407T1 (de) | 1992-08-15 |
| AU625802B2 (en) | 1992-07-16 |
| DE68902212D1 (de) | 1992-08-27 |
| CA2000999A1 (en) | 1990-04-21 |
| JP2807506B2 (ja) | 1998-10-08 |
| EP0365087A1 (en) | 1990-04-25 |
| IE893324L (en) | 1990-04-21 |
| ZA897895B (en) | 1990-07-25 |
| NZ231095A (en) | 1992-03-26 |
| FI100305B (fi) | 1997-11-14 |
| EP0365087B1 (en) | 1992-07-22 |
| ES2051989T3 (es) | 1994-07-01 |
| JPH02169523A (ja) | 1990-06-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX165003B (es) | Procedimiento para la preparacion de conjugados de medicamentos citotoxicos | |
| FI963424A (fi) | Menetelmä terapeuttisesti aktiivisten tiofeenisulfonamidien valmistamiseksi | |
| NO174392C (no) | Analogifremgangsmåte for fremstilling av acyldeoksyribonukleosidderivater | |
| NO904986L (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive diazepin-derivater. | |
| CA2043033A1 (fr) | Utilisation du baclofene pour l'obtention de medicaments destines au traitement de l'angine de poitrine | |
| IE861997L (en) | Zwitterionic bicyclic compounds | |
| MD306B1 (ro) | Remediu pentru profilaxia afectiunilor vasculare determinate de actiunea peroxizilor glicoproteinfixati | |
| NO924025D0 (no) | Antistoffkonjugater for behandling av neoplastisk sykdom | |
| ES2089136T3 (es) | Tratamiento de enfermedades inflamatorias con la ayuda de derivados 15-ceto-prostaglandinas. | |
| ES2064613T3 (es) | Produccion de agentes citotoxicos. | |
| SE8404283L (sv) | Anvendning av ett specifikt tumorassocierat antigen, nemligen sialosyllaktotetraos, for diagnostiska och terapeutiska forfaranden vid cancersjukdomar | |
| FI895005A0 (fi) | Immunotoxiner foer behandling och profylax av autoimmuna sjukdomar. | |
| FR2651435B1 (fi) | ||
| NO891894L (no) | Fremgangsmaate for fremstilling av antikoagulerende peptidalkoholer. | |
| GR3022706T3 (en) | Use of 15-dehydroxy-16-oxoprostaglandin derivatives in the treatment of allergic diseases | |
| EP0299057A4 (en) | INCREASING THE POWER OF CYTOTOXIC CONJUGATES. | |
| ES2093656T3 (es) | Preparaciones combinadas farmaceuticas que contienen cefotaxima y derivados de la xantina y su uso. | |
| GR3005231T3 (fi) | ||
| FR2646607B1 (fr) | Anticorps monoclonaux anti-b2 microglobuline | |
| NO903408L (no) | Terapeutisk anvendelse av anti-t-celle-immunotoksin for autoimmunsykdommer. | |
| ATE90565T1 (de) | Behandlung des schocks mit cyclodextrin und dessen derivaten. | |
| FI953708A0 (fi) | Menetelmä terapeuttisesti aktiivisten makrosyklisten bifunktionaalisten kelaatinmuodostajien, niiden kompleksien sekä niiden vasta-ainekonjugaattien valmistamiseksi | |
| IT8748339A0 (it) | Composizioni farmaceutiche ad atti vita'antineoplastica | |
| IT1243368B (it) | Uso del bendazac e dei suoi sali farmaceuticamente accettabili |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MM | Patent lapsed |
Owner name: AKZO N.V. |